ロード中...
Trivalent Vaccine against Botulinum Toxin Serotypes A, B, and E That Can Be Administered by the Mucosal Route
Most reports dealing with vaccines against botulinum toxin have focused on the injection route of administration. This is unfortunate, because a mucosal vaccine is likely to be more efficacious for patients and pose fewer risks to health care workers and to the environment. Therefore, efforts were m...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1932861/ https://ncbi.nlm.nih.gov/pubmed/17371853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.01893-06 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|